Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer

作者: Ashesh B. Jani , Jeffrey M. Feinstein , Robert Pasciak , Samuel Krengel , Ralph R. Weichselbaum

DOI: 10.1016/J.UROLOGY.2005.11.008

关键词:

摘要: Abstract Objectives To report a single-institution experience and analysis of the role supplemental external beam radiotherapy (EBRT) with brachytherapy. EBRT is often used in addition to low-dose-rate brachytherapy treatment prostate cancer, particularly for disease adverse features. Methods A cohort 189 consecutive patients, who had undergone at our institution demographic, disease, information minimum 2 years follow-up available, constituted study group. This was divided into two major groups according use EBRT. Using successive prostate-specific antigen rises greater than 1 ng/mL as definition failure, biochemical failure-free survival curves were constructed no-EBRT compared using log-rank test. Additionally, multivariate all factors performed Cox proportional hazards model. Results Despite proportion group, 5-year rate versus 80% 59%, respectively ( P = 0.043). Conclusions In study, conferred significant control advantage when added Because not designed permit detailed subset analyses, more work needed determine precise population that will benefit from this

参考文章(24)
Maged Ghaly, Kent Wallner, Gregory Merrick, Lawrence True, Steven Sutlief, William Cavanagh, Wayne Butler, The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials. International Journal of Radiation Oncology Biology Physics. ,vol. 55, pp. 1288- 1293 ,(2003) , 10.1016/S0360-3016(02)04527-3
Beth Dawson-Saunders, Robert G. Trapp, Basic and Clinical Biostatistics ,(1993)
L Potters, P Fearn, M Kattan, The role of external radiotherapy in patients treated with permanent prostate brachytherapy. Prostate Cancer and Prostatic Diseases. ,vol. 5, pp. 47- 53 ,(2002) , 10.1038/SJ.PCAN.4500552
Subir Nag, David Beyer, Jay Friedland, Peter Grimm, Ravinder Nath, None, American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer International Journal of Radiation Oncology Biology Physics. ,vol. 44, pp. 789- 799 ,(1999) , 10.1016/S0360-3016(99)00069-3
Richard E Peschel, John W Colberg, Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncology. ,vol. 4, pp. 233- 241 ,(2003) , 10.1016/S1470-2045(03)01035-0
John C. Blasko, Peter D. Grimm, John E. Sylsvester, William Cavanagh, The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiotherapy and Oncology. ,vol. 57, pp. 273- 278 ,(2000) , 10.1016/S0167-8140(00)00288-7
Ashesh B. Jani, Christopher M. Hand, Anthony E. Lujan, John C. Roeske, Gregory P. Zagaja, Srinivasan Vijayakumar, Charles A. Pelizzari, Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans Medical Dosimetry. ,vol. 29, pp. 42- 48 ,(2004) , 10.1016/J.MEDDOS.2003.09.005
Jacques Corriveau, Kent Wallner, Gregory Merrick, Lawrence True, William Cavanagh, Steven Sutlief, Wayne Butler, Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy. Brachytherapy. ,vol. 2, pp. 108- 113 ,(2003) , 10.1016/S1538-4721(03)00099-0
Cheng B Saw, Ali S Meigooni, Ravinder Nath, None, Review of AAPM task group no. 43 recommendations on interstitial brachytherapy sources dosimetry Medical Dosimetry. ,vol. 23, pp. 259- 263 ,(1998) , 10.1016/S0958-3947(98)00027-2
Gerard C. Morton, Early prostate cancer. Current Problems in Cancer. ,vol. 24, pp. 7- 51 ,(2000) , 10.1016/S0147-0272(00)90007-2